Here’s a startling fact: millions of lives hang in the balance due to gaps in immunization efforts, and the clock is ticking. But here’s where it gets controversial—while global initiatives aim for universal vaccine access, regional disparities and resource constraints threaten to leave entire communities behind. Enter the WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG), a powerhouse of experts dedicated to bridging this divide. Established by the WHO Regional Director for South-East Asia, this group isn’t just another committee—it’s the backbone of evidence-based immunization strategies in the region, aligning local efforts with global goals like the Immunization Agenda 2030 (IA2030) and the Regional Vaccine Implementation Plan (RVIP) 2022–2026.
SEAR-ITAG is no ordinary assembly. Comprised of specialists in program management, communicable disease control, virology, epidemiology, immunization, and behavioral sciences, this group meets annually—and more frequently when crises demand it. Their mission? To review progress, tackle emerging challenges, and recommend bold actions to strengthen immunization systems and combat vaccine-preventable diseases (VPDs). And this is the part most people miss—they also provide real-time technical guidance to ensure regional efforts stay on track. Think of them as the navigators steering the ship through stormy seas of public health.
The sixteenth meeting of SEAR-ITAG, held in a hybrid format in New Delhi, India, from September 16 to 18, 2025, was a game-changer. With 175 participants—64 in-person and 111 virtual—it brought together SEAR-ITAG members, representatives from National Technical Advisory Groups (NITAGs), National Immunization Programmes (NIPs) across all ten Member States, WHO officials, and delegates from powerhouse organizations like UNICEF, Gavi, CEPI, and the World Bank. Even vaccine manufacturers and other stakeholders were in the room, ensuring every angle was covered.
This meeting wasn’t just another check-in—it was a pivotal moment. As the RVIP 2022–2026 nears completion, the focus shifted to accelerating progress and laying the groundwork for post-2026 strategies. Building on insights from key forums like the Regional Certification Commission for Polio Eradication (SEA-RCCPE) and the Regional Verification Commission for Measles and Rubella Elimination (SEA-RVC), the agenda was packed. Goals included reviewing progress toward RVIP targets, tackling persistent issues like zero-dose children and subnational disparities, and kickstarting expert consultations for the next RVIP cycle. Here’s the bold question—can we truly eliminate vaccine-preventable diseases if millions still lack access to basic immunizations?
The discussions didn’t shy away from tough realities. Resource constraints, shifting donor priorities, and the need for resilient health systems dominated conversations. Yet, SEAR-ITAG’s commitment to equity-driven strategies, innovation in service delivery, and community engagement shone through. From data management to grassroots mobilization, every aspect of immunization was scrutinized and strengthened.
As the meeting concluded, one thing was clear: SEAR-ITAG isn’t just advising—it’s leading the charge. Their work ensures that WHO and its Member States tackle complex immunization challenges head-on, striving to leave no one behind. But the question remains—are we doing enough? What’s your take? Do you think current strategies will bridge the immunization gap, or is a radical rethink needed? Let’s spark the debate in the comments!
